| 1 |
Wu MY, Li CJ, Hou MF, et al. New insights into the role of inflammation in the pathogenesis of atherosclerosis [J]. Int J Mol Sci, 2017, 18(10): 2034.
|
| 2 |
Khosravi M, Poursaleh A, Ghasempour G, et al. The effects of oxidative stress on the development of atherosclerosis [J]. Biol Chem, 2019, 400(6): 711-732.
|
| 3 |
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis [J]. Nature, 2011, 473(7347): 317-325.
|
| 4 |
Watanabe Y, Nagayama M, Sakata A, et al. Evaluation of fibrous cap rupture of atherosclerotic carotid plaque with thin-slice source images of time-of-flight MR angiography [J]. Ann Vasc Dis, 2014, 7(2): 127-133.
|
| 5 |
Feinberg MW, Moore KJ. MicroRNA regulation of atherosclerosis [J]. Circ Res, 2016, 118(4): 703-720.
|
| 6 |
Huang Y, Shen X, Zou Q, et al. Biological functions of microRNAs [J]. Bioorg Khim, 2010, 36: 747-752.
|
| 7 |
Hajibabaie F, Kouhpayeh S, Mirian M, et al. MicroRNAs as the actors in the atherosclerosis scenario [J]. J Physiol Biochem, 2020, 76(1): 1-12.
|
| 8 |
Andreou I, Sun X, Stone PH, et al. miRNAs in atherosclerotic plaque initiation, progression, and rupture [J]. Trends Mol Med, 2015, 21(5): 307-318.
|
| 9 |
柴捷, 龙熙, 陈磊, 等. MiRNA突变改变其功能 [J]. 生命的化学, 2020, 40(10): 1722-1729.
|
| 10 |
Correia de Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs' action through miRNA editing [J]. Int J Mol Sci, 2019, 20(24): 6249.
|
| 11 |
Wang H, Liu D, Zhang H. Investigation of the underlying genes and mechanism of macrophage-enriched ruptured atherosclerotic plaques using bioinformatics method [J]. J Atheroscler Thromb, 2019, 26(7): 636-658.
|
| 12 |
Laffont B, Rayner KJ. MicroRNAs in the pathobiology and therapy of atherosclerosis [J]. Can J Cardiol, 2017, 33(3): 313-324.
|
| 13 |
赵晨, 贾海波, 李丽丽. 炎症反应对于冠状动脉斑块易损性的影响 [J]. 中国介入心脏病学杂志, 2020, 28(3): 163-166.
|
| 14 |
Bentzon JF, Otsuka F, Virmani R, et al. Mechanisms of plaque formation and rupture [J]. Circ Res, 2014, 114(12): 1852-1866.
|
| 15 |
Solly EL, Dimasi CG, Bursill CA, et al. MicroRNAs as therapeutic targets and clinical biomarkers in atherosclerosis [J]. J Clin Med, 2019, 8(12): 2199.
|
| 16 |
尹婕, 李琦, 赵正, 等. 纤维化对动脉粥样硬化斑块稳定性的基础研究及相关药物应用 [J]. 中国中药杂志, 2019, 44(2): 235-241.
|
| 17 |
Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis [J]. Circ Res, 2016, 118(4): 692-702.
|
| 18 |
Bazan HA, Hatfield SA, O'Malley CB, et al. Acute loss of miR-221 and miR-222 in the atherosclerotic plaque shoulder accompanies plaque rupture [J]. Stroke, 2015, 46(11): 3285-3287.
|
| 19 |
Lovren F, Pan Y, Quan A, et al. MicroRNA-145 targeted therapy reduces atherosclerosis [J]. Circulation, 2012, 126(11 Suppl 1): S81-S90.
|
| 20 |
Castoldi G, Di Gioia CR, Bombardi C, et al. MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension [J]. J Cell Physiol, 2012, 227(2): 850-856.
|
| 21 |
Leistner DM, Boeckel JN, Reis SM, et al. Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristicsv [J]. Eur Heart J, 2016, 37(22): 1738-1749.
|
| 22 |
Lu Y, Thavarajah T, Gu W, et al. Impact of miRNA in atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2018, 38(9): e159-e170.
|
| 23 |
Santovito D, Egea V, Weber C. Small but smart: microRNAs orchestrate atherosclerosis development and progression [J]. Biochim Biophys Acta, 2016, 1861(12 Pt B): 2075-2086.
|
| 24 |
张智鑫, 王博. 影响颈动脉斑块稳定性的机制研究进 [J]. 世界最新医学信息文摘, 2019, 19(30): 95-96, 98.
|
| 25 |
Liu H, Xiong W, Liu F, et al. MicroRNA-133b regulates the growth and migration of vascular smooth muscle cells by targeting matrix metallopeptidase 9 [J]. Pathol Res Pract, 2019, 215(5): 1083-1088.
|
| 26 |
Gonzalez L, Trigatti BL. Macrophage apoptosis and necrotic core development in atherosclerosis: a rapidly advancing field with clinical relevance to imaging and therapy [J]. Can J Cardiol, 2017, 33(3): 303-312.
|
| 27 |
Das A, Ganesh K, Khanna S, et al. Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation [J]. J Immunol, 2014, 192(3): 1120-1129.
|
| 28 |
Wei Y, Zhu M, Corbalán-Campos J, et al. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2015, 35(4): 796-803.
|
| 29 |
Hoseini Z, Sepahvand F, Rashidi B, et al. NLRP3 inflammasome: its regulation and involvement in atherosclerosis [J]. J Cell Physiol, 2018, 233(3): 2116-2132.
|
| 30 |
Yang S, Ye ZM, Chen S, et al. MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1/G1 in macrophages [J]. J Mol Cell Cardiol, 2018, 123: 139-149.
|
| 31 |
Chipont A, Esposito B, Challier I, et al. MicroRNA-21 deficiency alters the survival of Ly-6Clo monocytes in ApoE-/- mice and reduces early-stage atherosclerosis-brief report [J]. Arterioscler Thromb Vasc Biol, 2019, 39(2): 170-177.
|
| 32 |
Camaré C, Pucelle M, Nègre-Salvayre A, et al. Angiogenesis in the atherosclerotic plaque [J]. Redox Biol, 2017, 12: 18-34.
|
| 33 |
Wei Y, Schober A, Weber C. Pathogenic arterial remodeling: the good and bad of microRNAs [J]. Am J Physiol Heart Circ Physiol, 2013, 4(8): H1050-9.
|
| 34 |
Madrigal-Matute J, Rotllan N, Aranda JF, et al. MicroRNAs and atherosclerosis [J]. Curr Atheroscler Rep, 2013, 15(5): 322.
|
| 35 |
Urbich C, Kaluza D, Frömel T, et al. MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A [J]. Blood, 2012, 119(6): 1607-1616.
|
| 36 |
Chang SH, Hla T. Gene regulation by RNA binding proteins and microRNAs in angiogenesis [J]. Trends Mol Med, 2011, 17(11): 650-658.
|